Osmosun (ALWTR) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
17 Aug, 2026Executive summary
H1 2025 saw revenues fall to €616K from €1,505K year-over-year, reflecting operational scaling challenges and financial pressure.
Net loss improved to €1,460K in H1 2025 from €2,633K in H1 2024.
Unibios acquired a 65% stake in July 2025, injecting €2M and merging OSMOSUN with Watera to form a new entity.
The new group aims to become a global leader in sustainable water and wastewater treatment and reuse.
New governance and organizational structure target profitable growth and operational excellence.
Financial highlights
H1 2025 revenues: €616K, down from €1,505K in H1 2024; gross margin improved to €741K from €616K.
EBITDA improved to -€1,246K from -€2,495K year-over-year.
Operating loss: €1,400K (H1 2025) vs. €2,700K (H1 2024).
Unibios Group H1 2025 revenues: €5.8M, EBITDA €2.3M (35.7% margin), net income €1.4M.
Shareholders' equity negative €0.3M at 30 June 2025; post-transaction proforma equity €8.3M.
Outlook and guidance
Strategic focus on expanding in water treatment and reuse markets, targeting both organic growth and acquisitions.
Cost reduction plan of €1.2M for 2025, with FTE reduction from 32 to 18 and significant savings in general expenses.
Ambition to achieve a normative EBITDA margin of 15% in line with Watera International's standards.
New manufacturing facility in Volos, Greece, to be operational by end of 2025.
Latest events from Osmosun
- Losses narrowed and financial structure improved, with further profitability gains expected in 2026.ALWTR
H2 2025 - Revenue up 15% in H1 2024, but losses widened amid project delays and higher costs.ALWTR
H1 2024 - Losses deepened as project delays and higher costs strained liquidity, prompting urgent funding needs.ALWTR
H2 2024